(FILES) A picture taken on February 4, 2022 shows a screen bearing the new logo of French pharmaceutical group Sanofi which is presented on the day of the group's 2021 full year results at Sanofi headquarters in Paris. French pharmaceutical giant Sanofi boosted its profits in 2024, a year that saw its flagship product Dupixent exceed its sales target and marked by the commercial success of its bronchiolitis preventative treatment Beyfortus on January 30, 2025. (Photo by Eric PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)